JP2024503623A5 - - Google Patents

Info

Publication number
JP2024503623A5
JP2024503623A5 JP2023541041A JP2023541041A JP2024503623A5 JP 2024503623 A5 JP2024503623 A5 JP 2024503623A5 JP 2023541041 A JP2023541041 A JP 2023541041A JP 2023541041 A JP2023541041 A JP 2023541041A JP 2024503623 A5 JP2024503623 A5 JP 2024503623A5
Authority
JP
Japan
Prior art keywords
lnp
item
lipid
formula
peg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023541041A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024503623A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/011450 external-priority patent/WO2022150485A1/en
Publication of JP2024503623A publication Critical patent/JP2024503623A/ja
Publication of JP2024503623A5 publication Critical patent/JP2024503623A5/ja
Pending legal-status Critical Current

Links

JP2023541041A 2021-01-06 2022-01-06 カプセル化rnaポリヌクレオチド及び使用方法 Pending JP2024503623A (ja)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US202163134376P 2021-01-06 2021-01-06
US63/134,376 2021-01-06
US202163147959P 2021-02-10 2021-02-10
US63/147,959 2021-02-10
US202163181917P 2021-04-29 2021-04-29
US202163181663P 2021-04-29 2021-04-29
US202163181899P 2021-04-29 2021-04-29
US63/181,899 2021-04-29
US63/181,917 2021-04-29
US63/181,663 2021-04-29
PCT/US2022/011450 WO2022150485A1 (en) 2021-01-06 2022-01-06 Encapsulated rna polynucleotides and methods of use

Publications (2)

Publication Number Publication Date
JP2024503623A JP2024503623A (ja) 2024-01-26
JP2024503623A5 true JP2024503623A5 (cg-RX-API-DMAC7.html) 2025-02-03

Family

ID=82357635

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023541041A Pending JP2024503623A (ja) 2021-01-06 2022-01-06 カプセル化rnaポリヌクレオチド及び使用方法

Country Status (7)

Country Link
US (1) US20240115636A1 (cg-RX-API-DMAC7.html)
EP (1) EP4274591A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024503623A (cg-RX-API-DMAC7.html)
KR (1) KR20230143141A (cg-RX-API-DMAC7.html)
AU (1) AU2022206676A1 (cg-RX-API-DMAC7.html)
CA (1) CA3204244A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022150485A1 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20250049948A1 (en) * 2021-11-16 2025-02-13 Sail Biomedicines, Inc. Novel ionizable lipids and lipid nanoparticles and methods of using the same
WO2023223183A1 (en) * 2022-05-16 2023-11-23 Crispr Therapeutics Ag Picornaviral vectors for gene editing
WO2024031078A2 (en) * 2022-08-05 2024-02-08 Elevatebio Technologies, Inc. Chimeric oncolytic viruses with tropism for poliovirus receptor
IL320573A (en) 2022-11-04 2025-07-01 Life Edit Therapeutics Inc Developed adenine deaminases and RNA-guided nuclease fusion proteins with internal insertion sites and methods of use
EP4642914A1 (en) * 2022-12-28 2025-11-05 ST Pharm. Co., Ltd. Compositions and methods for generating circular rna
CN120826390A (zh) 2023-01-31 2025-10-21 安斯泰来制药株式会社 具有环状胺的氨甲酰基脂质或脲脂质、含有其的脂质纳米粒子和药物组合物
TW202438672A (zh) * 2023-01-31 2024-10-01 美商亞克圖羅斯醫療公司 四價流感疫苗之方法及組成物
WO2024178397A2 (en) 2023-02-24 2024-08-29 Elevatebio Technologies, Inc. Modified immune effector cells and methods of use
WO2024226832A1 (en) * 2023-04-25 2024-10-31 Orgenesis Inc. Ribonucleases for treating viral infections
EP4750890A2 (en) 2023-07-27 2026-06-03 Life Edit Therapeutics, Inc. Rna-guided nucleases and active fragments and variants thereof and methods of use
CN122422501A (zh) 2023-10-18 2026-07-17 生命编辑治疗股份有限公司 Rna引导的核酸酶及其活性片段和变体以及使用方法
WO2025174908A1 (en) 2024-02-12 2025-08-21 Life Edit Therapeutics, Inc. Novel rna-guided nucleases and proteins for polymerase editing
TW202617985A (zh) 2024-06-25 2026-05-01 美商生命編輯治療學公司 新穎反轉錄酶及其用途
WO2026006491A1 (en) * 2024-06-25 2026-01-02 Cornell University Senecavirus a (sva) vaccine compositions and methods thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102166218A (zh) * 2005-01-17 2011-08-31 溶瘤病毒有限公司 治疗肿瘤的方法和组合物
DK3386484T3 (da) * 2015-12-10 2022-07-04 Modernatx Inc Sammensætninger og fremgangsmåder til afgivelse af terapeutiske midler
RU2020106730A (ru) * 2017-07-14 2021-08-16 Онкорус, Инк. Инкапсулированные полинуклеотиды и способы их применения
MX2020002348A (es) * 2017-08-31 2020-10-08 Modernatx Inc Métodos de elaboración de nanopartículas lipídicas.
ES3001512T3 (en) * 2018-04-29 2025-03-05 Global Life Sciences Solutions Canada Ulc Compositions for transfecting resistant cell types
CA3124524A1 (en) * 2019-01-04 2020-07-09 Oncorus, Inc. Encapsulated rna polynucleotides and methods of use
KR102732019B1 (ko) * 2019-04-15 2024-11-20 글로벌 라이프 사이언시즈 솔루션즈 캐나다 유엘씨 T 세포 유전자 발현의 비바이러스 변형

Similar Documents

Publication Publication Date Title
JP2022516318A5 (cg-RX-API-DMAC7.html)
Wang et al. mRNA-based vaccines and therapeutics: an in-depth survey of current and upcoming clinical applications
ES2256265T3 (es) Vectores de parvovirus duplicados.
KR102142180B1 (ko) 세포에 핵산을 도입하기 위한 조성물
JP2025063030A5 (cg-RX-API-DMAC7.html)
JP2023528300A5 (cg-RX-API-DMAC7.html)
TW202425953A (zh) 脂質奈米顆粒 (lnp) 綴合物的製備
Cai et al. Synthetic circRNA therapeutics: innovations, strategies, and future horizons
JP2024531486A (ja) 環状rnaを調製するための構築物及び方法
JP2024503623A (ja) カプセル化rnaポリヌクレオチド及び使用方法
JP2026012402A5 (cg-RX-API-DMAC7.html)
Son et al. Development of mRNA vaccines/therapeutics and their delivery system
Zwolsman et al. Engineering lipid nanoparticles for mRNA immunotherapy
CN101307328A (zh) 一种ck19重组腺相关病毒载体及其构建方法与应用
JP2022507269A5 (cg-RX-API-DMAC7.html)
Kairuz et al. Advancing mRNA technologies for therapies and vaccines: An African context
CN110168090A (zh) mRNA的功能化方法
JP2023528300A (ja) 封入されたrnaレプリコンおよび使用方法
WO2022069577A1 (en) Engineered extracellular vesicles displaying enhanced pharmacokinetics
CA3143627A1 (en) Carbohydrate nanocarrier delivery of hepatitis b virus (hbv) vaccines
WO2024131403A1 (zh) 基于核酸适体的脾脏及其亚细胞的mRNA靶向递送系统
Qu et al. Critical considerations of mRNA–LNP technology for CAR-T therapy: components, payloads and emerging horizons
Yang et al. Advancing cancer treatment: in vivo delivery of therapeutic small noncoding RNAs
Wang et al. Targeted gene delivery systems for T-cell engineering
CN116726198B (zh) 一种抗肿瘤药物及其在脑胶质瘤治疗中的应用